These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12045171)

  • 1. Roxithromycin treatment prevents progression of peripheral arterial occlusive disease in Chlamydia pneumoniae seropositive men: a randomized, double-blind, placebo-controlled trial.
    Wiesli P; Czerwenka W; Meniconi A; Maly FE; Hoffmann U; Vetter W; Schulthess G
    Circulation; 2002 Jun; 105(22):2646-52. PubMed ID: 12045171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of peripheral arterial occlusive disease is associated with Chlamydia pneumoniae seropositivity and can be inhibited by antibiotic treatment.
    Krayenbuehl PA; Wiesli P; Maly FE; Vetter W; Schulthess G
    Atherosclerosis; 2005 Mar; 179(1):103-10. PubMed ID: 15721015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of roxithromycin treatment on the endothelial function of Chlamydia pneumoniae seropositive men suffering from peripheral arterial occlusive disease.
    Wiesli P; Schulthess G
    Circulation; 2002 Dec; 106(25):e226; author reply e226. PubMed ID: 12485976
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial.
    Neumann F; Kastrati A; Miethke T; Pogatsa-Murray G; Mehilli J; Valina C; Jogethaei N; da Costa CP; Wagner H; Schömig A
    Lancet; 2001 Jun; 357(9274):2085-9. PubMed ID: 11445102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced progression of early carotid atherosclerosis after antibiotic treatment and Chlamydia pneumoniae seropositivity.
    Sander D; Winbeck K; Klingelhöfer J; Etgen T; Conrad B
    Circulation; 2002 Nov; 106(19):2428-33. PubMed ID: 12417538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody levels against Chlamydia pneumoniae and outcome of roxithromycin therapy in patients with acute myocardial infarction. Results from a sub-study of the randomised Antibiotic Therapy in Acute Myocardial Infarction (ANTIBIO) trial.
    Burkhardt U; Zahn R; Höffler U; Siegler KE; Frilling B; Weber M; Gottwik M; Wehr M; Seidel F; Rosocha S; Tebbe U; Senges J
    Z Kardiol; 2004 Sep; 93(9):671-8. PubMed ID: 15365734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can long-term antibiotic treatment prevent progression of peripheral arterial occlusive disease? A large, randomized, double-blinded, placebo-controlled trial.
    Joensen JB; Juul S; Henneberg E; Thomsen G; Ostergaard L; Lindholt JS
    Atherosclerosis; 2008 Feb; 196(2):937-42. PubMed ID: 17418218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae.
    Black PN; Blasi F; Jenkins CR; Scicchitano R; Mills GD; Rubinfeld AR; Ruffin RE; Mullins PR; Dangain J; Cooper BC; David DB; Allegra L
    Am J Respir Crit Care Med; 2001 Aug; 164(4):536-41. PubMed ID: 11520711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roxithromycin in prevention of acute coronary syndrome associated with Chlamydia pneumoniae infection: a randomized placebo controlled trial.
    Leowattana W; Bhuripanyo K; Singhaviranon L; Akaniroj S; Mahanonda N; Samranthin M; Pokum S
    J Med Assoc Thai; 2001 Dec; 84 Suppl 3():S669-75. PubMed ID: 12002908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlamydia pneumoniae, antibiotic treatment, and early atherosclerosis.
    Liuba P; Pesonen E; Paakkari I
    Circulation; 2003 Jun; 107(22):e205; author reply e205. PubMed ID: 12796417
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study.
    Mosorin M; Juvonen J; Biancari F; Satta J; Surcel HM; Leinonen M; Saikku P; Juvonen T
    J Vasc Surg; 2001 Oct; 34(4):606-10. PubMed ID: 11668312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic therapy after acute myocardial infarction: a prospective randomized study.
    Zahn R; Schneider S; Frilling B; Seidl K; Tebbe U; Weber M; Gottwik M; Altmann E; Seidel F; Rox J; Höffler U; Neuhaus KL; Senges J;
    Circulation; 2003 Mar; 107(9):1253-9. PubMed ID: 12628944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of early carotid atherosclerosis is only temporarily reduced after antibiotic treatment of Chlamydia pneumoniae seropositivity.
    Sander D; Winbeck K; Klingelhöfer J; Etgen T; Conrad B
    Circulation; 2004 Mar; 109(8):1010-5. PubMed ID: 14769704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlamydia pneumoniae eradication from carotid plaques. Results of an open, randomised treatment study.
    Melissano G; Blasi F; Esposito G; Tarsia P; Dordoni L; Arosio C; Tshomba Y; Fagetti L; Allegra L; Chiesa R
    Eur J Vasc Endovasc Surg; 1999 Oct; 18(4):355-9. PubMed ID: 10550273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of IgG-seropositivity to Chlamydia pneumoniae in early thrombotic events after coronary stent placement.
    da Costa CP; Neumann FJ; Kastrati A; Stallforth I; Schmid M; Joghetai N; Prebeck S; Wagner H; Miethke T
    Atherosclerosis; 2003 Jan; 166(1):171-6. PubMed ID: 12482564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.
    Ogrendik M
    Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study.
    Anderson JL; Muhlestein JB; Carlquist J; Allen A; Trehan S; Nielson C; Hall S; Brady J; Egger M; Horne B; Lim T
    Circulation; 1999 Mar; 99(12):1540-7. PubMed ID: 10096928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of carotid plaque inflammation and Chlamydia pneumoniae infection with cerebrovascular symptomatology.
    Kaperonis EA; Liapis CD; Kakisis JD; Perrea D; Kostakis AG; Karayannakos PE
    J Vasc Surg; 2006 Dec; 44(6):1198-204. PubMed ID: 17145421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Percentage of asthmatic patients with acute bronchitis and Chlamydia pneumoniae seropositivity].
    Orfila J; Godard P
    Presse Med; 2000 Sep; 29(25):1439-41. PubMed ID: 11036523
    [No Abstract]   [Full Text] [Related]  

  • 20. Chlamydia pneumoniae-atherosclerosis link: a sound concept in search for clinical relevance.
    Neumann FJ
    Circulation; 2002 Nov; 106(19):2414-6. PubMed ID: 12417534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.